Streetbeat News

FREQ

Frequency Therapeutics Inc

Employees

Industry

Pharmaceutical Preparation Manufacturing

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Frequency Therapeutics has terminated its sales agreement with Oppenheimer, effective immediately, according to an SEC filing. The termination is not subject to any penalties.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:12 pm

Several analysts have updated their price targets and ratings for various US-listed companies. American Airlines, IHS Holding, Nordson Corporation, Olin Corporation, Frequency Therapeutics, W. P. Carey, and NIKE have seen their price targets cut, while Flowserve Corporation, SiteOne Landscape Supply, DraftKings, and Wingstop have seen their price targets raised. The stocks' reactions to these updates varied, with some seeing their share prices fall and others rise.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 12:13 pm

Baird analyst Jack Allen has downgraded Frequency Therapeutics (NASDAQ:FREQ) from Outperform to Neutral and lowered the price target from $4 to $0.5.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 8:49 am

Several healthcare stocks experienced significant price movements during Monday's intraday session. Gainers included Timber Pharmaceuticals (TMBR), China SXT Pharmaceuticals (SXTC), Novo Integrated Sciences (NVOS), China Pharma Holding (CPHI), Fortress Biotech (FBIOP), and Orchestra BioMed Hldgs (OBIO). Losers included CNS Pharma (CNSP), Arcutis Biotherapeutics (ARQT), Modular Medical (MODD), Frequency Therapeutics (FREQ), Vivos Therapeutics (VVOS), and Aziyo Biologics (AZYO).

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 5:31 pm

Frequency Therapeutics reported Q2 losses of $(0.30) per share, beating the analyst consensus estimate of $(0.35) by 14.29%. This represents a 50.82% increase over losses from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:39 pm

The article lists the top 5 overbought health care stocks that may crash in Q3. These include TC Biopharm (TCBP), Biodesix (BDSX), Revolution Medicines (RVMD), Frequency Therapeutics (FREQ), and DICE Therapeutics (DICE). The companies are considered overbought as their Relative Strength Index (RSI) values are above 70, indicating they may be overvalued.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 12:15 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Trxade Health (MEDS), Advanced Health (AHI), Applied Therapeutics (APLT), TC BioPharm (TCBP), TRACON Pharma (TCON), and Frequency Therapeutics (FREQ) saw their shares rise, with Trxade Health leading the gainers with a 63.3% increase. On the other hand, Adamis Pharmaceuticals (ADMP), Aptevo Therapeutics (APVO), Biophytis (BPTS), Nevro (NVRO), SmileDirectClub (SDC), and Bio-Path Hldgs (BPTH) experienced declines, with Adamis Pharmaceuticals leading the losers with a 63.4% decrease.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:51 am

Several stocks experienced significant pre-market trading movements. Notable gainers include American Superconductor Corporation (AMSC), AgriFORCE Growing Systems Ltd. (AGRI), and TETRA Technologies, Inc. (TTI), which surged due to upcoming earnings reports and better-than-expected results. On the other hand, Polished.com Inc. (POL), Cybin Inc. (CYBN), and Yellow Corporation (YELL) fell due to restated financial statements, public offering of units, and bankruptcy preparations respectively.

Portfolio Pulse from Lisa Levin

August 01, 2023 | 12:57 pm

During Monday's pre-market session, several healthcare stocks experienced significant movements. Acumen Pharmaceuticals, BridgeBio Pharma, Healthcare Triangle, argenx, Lixte Biotech Hldgs, and Travere Therapeutics saw increases in their share prices, while ViewRay, Tivic Health Systems, Apellis Pharmaceuticals, Minerva Surgical, Frequency Therapeutics, and Virios Therapeutics experienced decreases.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 1:06 pm

Several stocks are experiencing significant pre-market movements. Acumen Pharmaceuticals, PainReform, Nova LifeStyle, argenx SE, AERWINS Technologies, BridgeBio Pharma, Nuvve Holding Corp., Cadrenal Therapeutics, Edgio, and Genprex are among the gainers. BYND Cannasoft Enterprises, ViewRay, Ebix, Frequency Therapeutics, Apellis Pharmaceuticals, Minerva Surgical, Baosheng Media Group Holdings, Western Acquisition Ventures Corp., Monopar Therapeutics, and 60 Degrees Pharmaceuticals are among the losers.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 12:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.